Dir
Stefan A. Dyckerhoff is a Director at Astera Labs, Inc. (NASDAQ: ALAB), where he recently sold 24,998 shares of common stock on April 17 and 20, 2026, at an average price of approximately $175 per share, totaling about $4.38 million, under a pre-arranged Rule 10b5-1 trading plan adopted on December 1, 2025.[[1]](https://www.marketbeat.com/instant-alerts/insider-selling-astera-labs-nasdaqalab-director-sells-8346-shares-of-stock-2026-04-21/)[[2]](https://www.investing.com/news/insider-trading-news/astera-labs-director-stefan-dyckerhoff-sells-over-43m-in-stock-93CH-4627428)[[3]](https://www.moomoo.com/news/post/68638157/astera-labs-alabus-director-sells-us-4-38-million-in)[[5]](https://www.stocktitan.net/sec-filings/ALAB/form-4-astera-labs-inc-insider-trading-activity-3960e6ead74a.html) These transactions included direct holdings as well as shares held indirectly through a trust and a limited partnership, reducing his positions significantly while retaining substantial ownership, such as 67,144 shares directly, 336,398 through a trust, and 6,614 through a limited partnership post-sale.[[2]](https://www.investing.com/news/insider-trading-news/astera-labs-director-stefan-dyckerhoff-sells-over-43m-in-stock-93CH-4627428)[[5]](https://www.stocktitan.net/sec-filings/ALAB/form-4-astera-labs-inc-insider-trading-activity-3960e6ead74a.html)
Dyckerhoff has a extensive history as a corporate director and insider across multiple technology and biotech companies, including Snowflake Inc., Pure Storage, Inc., Yext, Inc., Juniper Networks Inc., Corcept Therapeutics Inc., Restoration Robotics Inc., Threshold Pharmaceuticals Inc., Forty Seven, Inc., Cardica Inc., and Mattersight Corp.[[6]](https://www.benzinga.com/sec/insider-trades/0001484394/Stefan-Dyckerhoff) As of August 2025, he held 74,154 shares directly and 379,827 indirectly in Astera Labs, totaling 453,981 shares.[[4]](https://www.secform4.com/insider-holders/1736297.html) No specific education or early career details are available in the provided sources.
View full insider profile →
Discussion